Redwood City’s Guardant Health announced that it closed $30 million in Series B funding today, with Khosla Ventures leading the round, joined by new investor Pejman Mar Ventures and original backer Sequoia Capital. Guardant Health launched officially in February, tracking tumor mutations noninvasively and in real time. [Source: Guardant Health]